Other — Consolidated revenues
Geographic · Consolidated revenuesThermo Fisher Scientific Other — Consolidated revenues remained flat by 0.0% to $5.58B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 5.6%, from $5.28B to $5.58B. Over 2 years (FY 2023 to FY 2025), Other — Consolidated revenues shows relatively stable performance with a 3.5% CAGR.
Analysis
How to read this metric
An increase suggests growth in non-core business areas or expansion into new markets, while a decrease may indicate a strategic divestiture or declining performance in secondary segments.
Detailed definition
This metric represents the total revenue generated by business activities or geographic regions categorized as 'Other' w...
Peer comparison
Peers often report similar figures as 'Other' or 'Corporate/Unallocated' revenue, which typically represent a small percentage of total consolidated sales.
tmo_segment_other_consolidated_revenuesHistorical Data
| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $20.84B | $21.12B | $22.32B |
| YoY Change | — | +1.3% | +5.6% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's other — consolidated revenues?
- Thermo Fisher Scientific (TMO) reported other — consolidated revenues of $5.58B in Q4 2025.
- How has Thermo Fisher Scientific's other — consolidated revenues changed year-over-year?
- Thermo Fisher Scientific's other — consolidated revenues increased by 5.6% year-over-year, from $5.28B to $5.58B.
- What is the long-term trend for Thermo Fisher Scientific's other — consolidated revenues?
- Over 2 years (2023 to 2025), Thermo Fisher Scientific's other — consolidated revenues has grown at a 3.5% compound annual growth rate (CAGR), from $20.84B to $22.32B.
- What does other — consolidated revenues mean?
- The total revenue generated by business activities or regions not classified under the company's main operating segments.